Design, antiproliferative potency, and in silico studies of novel 5-methylfuran-3-yl)thio)-3-phenylquinazolin-4(3H)-one based derivatives as potential EGFR inhibitors
Abstract Quinazolinone derivatives have been broadly studied as anti-cancer drug candidates due to their potential to inhibit key signaling pathways involved in tumor progression. In the current study, new 2-[(4-substituted-5-methylfuran-3-yl)thio]-3-phenylquinazolin-4(3H)-one derivatives (2–10) wer...
Saved in:
| Main Authors: | Sara M. Soliman, Adel A.-H. Abdel-Rahman, Eman S. Nossier, Modather F. Hussein, Amr Sabry, Hagar S. El-Hema |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-12140-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-Yield Synthesis of <i>N</i><sup>4</sup>-(3-Chloro-4-fluorophenyl)-7-((4-methoxybenzyl)thio)quinazoline-4,6-diamine via <i>N</i>-(3-Chloro-4-fluorophenyl)-7-((4-methoxybenzyl)thio)-6-nitroquinazolin-4-amine
by: Susila Thapa, et al.
Published: (2025-01-01) -
Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
by: N. M. Gabitova, et al.
Published: (2023-07-01) -
EGFR tyrosine kinase inhibitor: design, synthesis, characterization, biological evaluation, and molecular docking of novel 1,3,4-oxadiazole, thio-methyl, and 1,2,3-triazole hybrids
by: Asma Khalaf Alshamari, et al.
Published: (2025-07-01) -
Targeting EGFR by newer 4,6-Bis((E)-4-hydroxy-3-methoxystyryl)-1-(aryl)pyrimidin-2(1H)-one analogues as antiproliferative agents: eco-friendly chemical modification, in-vitro and in-silico studies
by: Md. Faiyaz Ahsan, et al.
Published: (2025-12-01) -
The study of analgesic effect of 5-(furan-2-yl, 2-methylfuran-3-yl)-4-amino-1,2,4-triazole-3-thion derivatives
by: D. M. Danilchenko
Published: (2018-10-01)